ATE159102T1 - Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome - Google Patents

Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome

Info

Publication number
ATE159102T1
ATE159102T1 AT94912252T AT94912252T ATE159102T1 AT E159102 T1 ATE159102 T1 AT E159102T1 AT 94912252 T AT94912252 T AT 94912252T AT 94912252 T AT94912252 T AT 94912252T AT E159102 T1 ATE159102 T1 AT E159102T1
Authority
AT
Austria
Prior art keywords
respiratory distress
distress syndrome
adult respiratory
patient
serum antioxidant
Prior art date
Application number
AT94912252T
Other languages
English (en)
Inventor
John E Repine
Joanathan A Leff
Original Assignee
Webb Waring Inst For Biomedica
Univ Colorado
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Webb Waring Inst For Biomedica, Univ Colorado filed Critical Webb Waring Inst For Biomedica
Application granted granted Critical
Publication of ATE159102T1 publication Critical patent/ATE159102T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/30—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving catalase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96447—Factor VII (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT94912252T 1993-03-19 1994-03-18 Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome ATE159102T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/034,935 US5389522A (en) 1993-03-19 1993-03-19 Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients

Publications (1)

Publication Number Publication Date
ATE159102T1 true ATE159102T1 (de) 1997-10-15

Family

ID=21879562

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912252T ATE159102T1 (de) 1993-03-19 1994-03-18 Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome

Country Status (9)

Country Link
US (2) US5389522A (de)
EP (2) EP0757105A3 (de)
JP (1) JPH08511864A (de)
AT (1) ATE159102T1 (de)
AU (1) AU690106B2 (de)
CA (1) CA2158579C (de)
DE (1) DE69406115T2 (de)
NO (1) NO953689D0 (de)
WO (1) WO1994022016A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389522A (en) * 1993-03-19 1995-02-14 Repine; John E. Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients
US5504111A (en) * 1994-12-30 1996-04-02 Medichem Research, Inc. Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
US5679532A (en) * 1995-12-13 1997-10-21 University Technology Corporation Serum ferritin as a predictor of the acute respiratory distress syndrome
MXPA05005073A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
EP1562046A1 (de) * 2004-02-03 2005-08-10 B.R.A.H.M.S Aktiengesellschaft Diagnose von Sepsis durch selektive Bestimmung der Konzentration der Cu/Zn Superoxiddismutase (Cu/Zn SOD) in Patientenproben
US7998698B2 (en) * 2006-05-31 2011-08-16 Health Research Inc. Method for predicting susceptibility to radiation pneumonitis
JP5715636B2 (ja) * 2009-11-03 2015-05-13 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 循環系事象と虚血性事象を鑑別するためのＮＴ−ｐｒｏＡＮＰおよびＳＦｌｔ−１
SE535502C2 (sv) * 2010-09-14 2012-08-28 Calmark Sweden Ab System och metod för att analysera risk eller förekomst av organsvikt
WO2022234101A1 (en) * 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926732A (en) * 1973-02-16 1975-12-16 Alfa Laval Ab Method for assaying catalase in milk and other liquids
US5147783A (en) * 1988-05-27 1992-09-15 Ube Industries, Ltd. Methods to screen for ovarian cancer and myocardial infarction
US5389522A (en) * 1993-03-19 1995-02-14 Repine; John E. Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients

Also Published As

Publication number Publication date
NO953689D0 (no) 1995-09-19
AU690106B2 (en) 1998-04-23
AU6448194A (en) 1994-10-11
EP0689674A1 (de) 1996-01-03
EP0757105A3 (de) 1998-01-28
JPH08511864A (ja) 1996-12-10
DE69406115D1 (de) 1997-11-13
CA2158579C (en) 1999-01-26
US5639629A (en) 1997-06-17
EP0689674B1 (de) 1997-10-08
US5389522A (en) 1995-02-14
EP0757105A2 (de) 1997-02-05
WO1994022016A1 (en) 1994-09-29
DE69406115T2 (de) 1998-04-30
CA2158579A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
AU5754699A (en) Detection and determination of the stages of coronary artery disease
ATE115588T1 (de) Ein verfahren zur herstellung eines antikörpers, der zur bestimmung der anwesenheit eines menschlichen oncogens befähigt ist.
DE3853671D1 (de) Reagens und Verfahren zur Messung von Leukozyten und Hämoglobin im Blut.
DE69022786D1 (de) Verfahren zur Bestimmung der Konzentration von Glucose.
DE3765310D1 (de) Vorrichtung zur bestimmung von gaspartialdruecken im blut.
ATE159102T1 (de) Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome
GR3036865T3 (en) Improved in vitro method, kits and reagents for screening for blood coagulation defects
IT8124138A0 (it) Procedimento e apparecchio per determinare quantitativamente il livello di emoglobina in campioni biologici.
DE69022425D1 (de) Verfahren zur Bestimmung der funktionellen Wirkung von freiem Protein S oder Protein C in einer Plasmaprobe.
PL310050A1 (en) Novel activity of anticoagulant cofactor
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
DE3887528D1 (de) Verfahren zur bestimmung des sauerstoffgehaltes.
ATE221200T1 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
DE59108478D1 (de) Funktioneller Test zur Bestimmung der Protein S-Aktivität
NO884061D0 (no) Fremgangsmaate for regulering av surhetsgraden i et elektrolytisk bad.
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
ATE289067T1 (de) Verfahren und mittel zur bestimmung von jodid
ES2099876T3 (es) Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis.
DE69708102T2 (de) Verfahren und reagenz zur überwachung des blutspiegels von antiplättchen-verbindungen
AU5336796A (en) Method for detecting allergy
DE69628659D1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
DE69519475D1 (de) Verwendung der sialinsäurebestimmung zur bestimmung der alkoholaufnahme
DE59308274D1 (de) Verfahren und Standardlösung zur Bestimmung von Thyroxin (T4) oder Trijodthyronin (T3)
AU4753800A (en) Methods of diagnosing or treating depression
ATE65607T1 (de) Verfahren und vorrichtung unter verwendung photoempfindlicher halbleiterelektrode zur bestimmung eines analytes.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties